Jayme Steig

Jayme Steig

Auto-generated profile, based on publicly available information

Jayme Steig

North Dakota State Univ, Pharm Practice, Fargo, ND USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Substance Abuse
Verified
Journal Article
Closed access
AWAmy Werremeyer
Amy Werremeyer
SMSydney Mosher
Sydney Mosher
HEHeidi Eukel
Heidi Eukel
ESElizabeth Skoy
Elizabeth Skoy
JSJayme Steig
Jayme Steig
MSMark A. Strand
Mark A. Strand
Background: Health professionals may stigmatize and prefer social distance from patients with opioid misuse, leading to poorer quality of care provided. The degree to which pharmacists prefer social distance from patients with opioid misuse and opioid use disorder (OUD) is not known. Methods: Pharmacists ( n = 187) completed a survey comprised of demographics, attitudinal, and Social Distance Scale (SDS) questions based on a vignette patient who displayed opioid misuse. SDS question responses and total scores (maximum of 30; higher scores representing great preference for social distance) were tallied and associations with attitudes and demographics were examined. Results: Mean SDS total score was 16.32 (range 9–23). More than 59% of respondents had an SDS score >15, indicating overall lack of willingness to interact with the vignette patient. Females had a higher mean SDS score vs male pharmacists (16.58 vs. 15.36, respectively; p = 0.023). Pharmacists were more likely to prefer social distance from the vignette patient in personal situations (i.e. renting a room) than work-related interactions (i.e. providing patient education). Pharmacists with >10 years of experience, those without personal experience with a substance use disorder, those who strongly agreed that patients with OUD require excessive time and effort, and those who agreed that some people lack self-discipline to use prescription pain medication without becoming addicted had significantly higher SDS scores than pharmacists without these characteristics. Conclusions: Pharmacists expressed significant preference for social distance indicating stigmatization of patients with opioid misuse. Pharmacists were comfortable performing pharmacy tasks with patients with opioid misuse, but were less comfortable forming therapeutic relationships, an important tenet of patient-centered care. Efforts are needed to examine contributions to social distance preferences and implement measures to reduce them. Targeting of pharmacists with >10 years’ experience and without personal experience with OUD may also be most beneficial.

1 January 2022 in Substance Abuse
Verified
Journal Article
Closed access
AWAmy Werremeyer
Amy Werremeyer
MSMark A. Strand
Mark A. Strand
HEHeidi Eukel
Heidi Eukel
ESElizabeth Skoy
Elizabeth Skoy
JSJayme Steig
Jayme Steig
OFOliver Frenzel
Oliver Frenzel
Background: Pharmacist stigma via examination of social distance preference and negative attitudes toward persons who misuse opioids is prevalent and may lower the quality of care provided to patients. Few studies have previously extended beyond the immediate post-intervention period to examine stigma change. Methods: This longitudinal cohort study utilized a pre-survey administered before the training program, a post-survey immediately upon completion of the training program, and a delayed post-survey, administered 12 months after the training program. Co-primary outcomes were changes in social distance scale (SDS) total score from baseline to post-survey and from baseline to 12 months. Secondary outcomes included change in SDS question scores and change in negative attitudes. One hundred eighty-seven of the 1211 eligible pharmacists in the state completed the training. Matched responses of forty-four pharmacists who completed all three surveys were examined. Results: The mean total SDS score was significantly lower in the immediate post-training survey than the pre-training mean (14.75 vs. 16.57, p = .000). The 12 months mean total SDS score was also significantly lower than the pre-training mean (15.32 vs. 16.57, p = .017). Significant changes in negative attitudes from baseline to post-survey and from baseline to 12 months were seen. Conclusion: Stigma reduction components integrated into opioid training decreased pharmacist social distance preference and negative attitudes toward patients who misuse opioids immediately after the training and, most notably, were sustained for 12 months.

1 May 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
OFOliver Frenzel
Oliver Frenzel
HEHeidi Eukel
Heidi Eukel
ELEmily Lothspeich
Emily Lothspeich
ESElizabeth Skoy
Elizabeth Skoy
JSJayme Steig
Jayme Steig
AWAmy Werremeyer
Amy Werremeyer

31 July 2022 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
MSMark A. Strand
Mark A. Strand
HEHeidi N. Eukel
Heidi N. Eukel
OFOliver Frenzel
Oliver Frenzel
ESElizabeth Skoy
Elizabeth Skoy
JSJayme Steig
Jayme Steig
AWAmy Werremeyer
Amy Werremeyer

7 February 2023 in Public Health Nursing
Verified
Journal Article
Closed access
HEHeidi N. Eukel
Heidi N. Eukel
JSJayme Steig
Jayme Steig
AHAlyssa Hodges
Alyssa Hodges
BOBrianna O'GAry
Brianna O'GAry
MSMark A. Strand
Mark A. Strand

2 July 2024 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
ESElizabeth Skoy
Elizabeth Skoy
RLRebecca Linger
Rebecca Linger
HEHeidi Eukel
Heidi Eukel
SMSusan Murphy
Susan Murphy
OFOliver Frenzel
Oliver Frenzel
AWAmy Werremeyer
Amy Werremeyer